The establishment of EVISA is funded by the EU through
the Fifth Framework Programme (G7RT- CT- 2002- 05112).
Supporters of EVISA includes:
A coordination complex consisting of a gadolinium ion bound to a
hexadentate organic chelating agent such as
diethylenetriaminepentaacetic acid. Chelates of gadolinium are
frequently utilized as magnetic resonance imaging (MRI) contrast agents
and can be used to track nanoparticle-mediated drug delivery.